Literature DB >> 11807706

Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa.

Bruce Banwart, Mark L Splaingard, Philip M Farrell, Michael J Rock, Peter L Havens, Joel Moss, Mary E Ehrmantraut, Dara W Frank, Joseph T Barbieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11807706     DOI： 10.1086/338197

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  11 in total

1.  Anti-activator ExsD forms a 1:1 complex with ExsA to inhibit transcription of type III secretion operons.

Authors:  Julie Thibault; Eric Faudry; Christine Ebel; Ina Attree; Sylvie Elsen
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

Review 2.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.

Authors:  Carlos E Milla; James F Chmiel; Frank J Accurso; Donald R VanDevanter; Michael W Konstan; Geoffrey Yarranton; David E Geller
Journal:  Pediatr Pulmonol       Date:  2013-09-09

4.  Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.

Authors:  Jinghua Jia; Yanping Wang; Lei Zhou; Shouguang Jin
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

5.  Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.

Authors:  Vincent T Lee; Roger S Smith; Burkhard Tümmler; Stephen Lory
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.

Authors:  Manu Jain; Daniel Ramirez; Roopa Seshadri; Joanne F Cullina; Catherine A Powers; Grant S Schulert; Maskit Bar-Meir; Christine L Sullivan; Susanna A McColley; Alan R Hauser
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

7.  The Pseudomonas aeruginosa PA01 gene collection.

Authors:  Joshua Labaer; Qingqing Qiu; Anukanth Anumanthan; Wenhong Mar; Dongmei Zuo; T V S Murthy; Helen Taycher; Allison Halleck; Eugenie Hainsworth; Stephen Lory; Leonardo Brizuela
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

8.  Characterization of hydrogen peroxide production by Duox in bronchial epithelial cells exposed to Pseudomonas aeruginosa.

Authors:  Balázs Rada; Thomas L Leto
Journal:  FEBS Lett       Date:  2010-01-19       Impact factor: 4.124

9.  Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.

Authors:  Nina Reiniger; Martin M Lee; Fadie T Coleman; Christopher Ray; David E Golan; Gerald B Pier
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

10.  Cystic Fibrosis Lung Function Decline after Within-Host Evolution Increases Virulence of Infecting Pseudomonas aeruginosa.

Authors:  Peter Jorth; Samantha Durfey; Amir Rezayat; Jayanthi Garudathri; Anina Ratjen; Benjamin J Staudinger; Matthew C Radey; Alan Genatossio; Sharon McNamara; David A Cook; Moira L Aitken; Ronald L Gibson; Timothy L Yahr; Pradeep K Singh
Journal:  Am J Respir Crit Care Med       Date:  2021-03-01       Impact factor: 21.405
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.